Optimus prices COVID-19 drug at ₹630 for 10 capsules
The Hindu
Optimus Pharma has set the price of anti-viral drug Molnupiravir 200 mg at ₹630 for a strip of 10 capsules.The company had invested around $4 million in the drug and is ready to gear up the manufactur
Optimus Pharma has set the price of anti-viral drug Molnupiravir 200 mg at ₹630 for a strip of 10 capsules.
The company had invested around $4 million in the drug and is ready to gear up the manufacturing, CMD D.Srinivasa Reddy said on Thursday. Optimus introduced the drug under Molcovir brand following the Drugs Controller General of India (DCGI) granting EUA in treatment of adults with COVID-19 who had high risk of progression to disease.
Optimus pharma had internally developed the active pharmaceutical ingredient and the formulation in capsule form and had obtained DCGI approval by completing Phase 3 clinical trial on patients with mild COVID-19 in the country, he said. Senior executives of the company said with the recommended dose of Molnupiravir being 800 mg twice a day, the cost of the five-day treatment regimen would be almost ₹2,500.
The Thane police have arrested two co-founders of cryptocurrency exchange platform CoinDCX in connection with an alleged fraud of Rs 71.6 lakh, officials said
Meta Chief Executive Mark Zuckerberg is building a CEO agent to help him do his job, the Wall Street Journal reported
Insurance penetration and density are often misunderstood and do not reveal how many families are insured or whether they would be financially secure if the main earning member were to die. The real issue is not reach but adequacy, as households may have life insurance but not enough cover to replace lost income, leaving them financially vulnerable.
Five top firms lose ₹1 lakh crore in market value, with HDFC Bank experiencing the largest decline of ₹56,124.48 crore.
L&T confirms 95% of its West Asia project sites are safe, while addressing logistics challenges amid ongoing regional conflicts.
Mines Ministry to auction 19 critical mineral blocks on March 23, expanding strategic resources for clean energy and technology sectors.
Mines Ministry to auction 19 critical mineral blocks on March 23, expanding strategic resources for clean energy and technology sectors.
Five top firms lose ₹1 lakh crore in market value, with HDFC Bank experiencing the largest decline of ₹56,124.48 crore.
HDFC Bank terminates three senior officials over client onboarding issues at its DIFC branch amid ethical concerns following chairman's resignation.
Air India CEO warns of potential flight cuts and reduced travel demand due to rising fuel costs amid ongoing Gulf conflict.
Options are widely used by retail traders to speculate on the value of the stock for immediate gains and such behaviour in large scale can distort the market
India achieves 1 billion tonne coal production for the second consecutive year, ensuring stable energy supply and economic growth.
Generic drugmakers in India launch affordable Semaglutide versions, targeting a $1 billion diabetes and weight loss market.